• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1 受体结合部位种系抗体-Env 结构可提供疫苗设计信息。

HIV-1 CD4-binding site germline antibody-Env structures inform vaccine design.

机构信息

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.

Department of Biology, Stanford University, Stanford, CA, USA.

出版信息

Nat Commun. 2022 Oct 17;13(1):6123. doi: 10.1038/s41467-022-33860-2.

DOI:10.1038/s41467-022-33860-2
PMID:36253376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9576718/
Abstract

BG24, a VRC01-class broadly neutralizing antibody (bNAb) against HIV-1 Env with relatively few somatic hypermutations (SHMs), represents a promising target for vaccine strategies to elicit CD4-binding site (CD4bs) bNAbs. To understand how SHMs correlate with BG24 neutralization of HIV-1, we report 4.1 Å and 3.4 Å single-particle cryo-EM structures of two inferred germline (iGL) BG24 precursors complexed with engineered Env-based immunogens lacking CD4bs N-glycans. Structures reveal critical Env contacts by BG24 and identify antibody light chain structural features that impede Env recognition. In addition, biochemical data and cryo-EM structures of BG24 variants bound to Envs with CD4bs glycans present provide insights into N-glycan accommodation, including structural modes of light chain adaptations in the presence of the N276 glycan. Together, these findings reveal Env regions critical for germline antibody recognition and potential sites to alter in immunogen design.

摘要

BG24 是一种针对 HIV-1 包膜的 VRC01 类广谱中和抗体(bNAb),其体细胞超突变(SHM)相对较少,代表了一种有前途的疫苗策略靶点,可以诱导 CD4 结合位点(CD4bs)bNAb。为了了解 SHM 如何与 BG24 对 HIV-1 的中和作用相关,我们报告了两个推断的种系(iGL)BG24 前体与缺乏 CD4bs N-聚糖的工程化基于 Env 的免疫原复合物的 4.1Å 和 3.4Å 单颗粒冷冻电镜结构。结构揭示了 BG24 的关键 Env 接触,并确定了阻碍 Env 识别的抗体轻链结构特征。此外,结合了带有 CD4bs 聚糖的 Env 的 BG24 变体的生化数据和冷冻电镜结构提供了对 N-聚糖容纳的深入了解,包括在存在 N276 聚糖的情况下轻链适应的结构模式。总之,这些发现揭示了种系抗体识别的关键 Env 区域和免疫原设计中可能改变的潜在位点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795d/9576718/444102e1fea9/41467_2022_33860_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795d/9576718/e0bfb8872969/41467_2022_33860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795d/9576718/15f89d3504d3/41467_2022_33860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795d/9576718/fd2af896045b/41467_2022_33860_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795d/9576718/fded4c325477/41467_2022_33860_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795d/9576718/444102e1fea9/41467_2022_33860_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795d/9576718/e0bfb8872969/41467_2022_33860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795d/9576718/15f89d3504d3/41467_2022_33860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795d/9576718/fd2af896045b/41467_2022_33860_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795d/9576718/fded4c325477/41467_2022_33860_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795d/9576718/444102e1fea9/41467_2022_33860_Fig5_HTML.jpg

相似文献

1
HIV-1 CD4-binding site germline antibody-Env structures inform vaccine design.HIV-1 受体结合部位种系抗体-Env 结构可提供疫苗设计信息。
Nat Commun. 2022 Oct 17;13(1):6123. doi: 10.1038/s41467-022-33860-2.
2
HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.HIV-1 包膜糖基化修饰可被 VRC01 类种系返回复性的广泛中和抗体中和。
PLoS Pathog. 2018 Nov 5;14(11):e1007431. doi: 10.1371/journal.ppat.1007431. eCollection 2018 Nov.
3
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.基于中和作用的设计,产生了对 CH235 谱系 CD4bs 广谱中和抗体的未突变共同祖先具有高亲和力的 HIV-1 包膜三聚体。
PLoS Pathog. 2019 Sep 17;15(9):e1008026. doi: 10.1371/journal.ppat.1008026. eCollection 2019 Sep.
4
A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope.VRC13 样 bNAb 反应与 HIV-1 包膜中的复杂逃逸途径相关。
J Virol. 2024 Mar 19;98(3):e0172023. doi: 10.1128/jvi.01720-23. Epub 2024 Feb 27.
5
CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals.CD4 结合位点免疫原在转基因和野生型动物中引发了针对 HIV-1 的异源中和抗体。
Sci Immunol. 2023 Feb 17;8(80):eade6364. doi: 10.1126/sciimmunol.ade6364. Epub 2023 Feb 10.
6
Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.多种重组HIV-1包膜蛋白无法激活表达广泛中和抗HIV-1抗体PG9和447-52D的种系B细胞受体的B细胞。
J Virol. 2014 Mar;88(5):2645-57. doi: 10.1128/JVI.03228-13. Epub 2013 Dec 18.
7
Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.设计用于呈现CD4结合位点的高糖基化稳定核心免疫原优先被广泛中和抗体识别。
J Virol. 2014 Dec;88(24):14002-16. doi: 10.1128/JVI.02614-14. Epub 2014 Sep 24.
8
Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.去除保守的CD4结合位点近端聚糖导致的HIV-1包膜三聚体结构和抗原性变化
J Virol. 2016 Sep 29;90(20):9224-36. doi: 10.1128/JVI.01116-16. Print 2016 Oct 15.
9
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.聚糖掩蔽作用聚焦于 HIV-1 的 CD4 结合位点的免疫反应,并增强了 VRC01 类前体抗体的产生。
Immunity. 2018 Aug 21;49(2):301-311.e5. doi: 10.1016/j.immuni.2018.07.005. Epub 2018 Jul 31.
10
Highly mutated antibodies capable of neutralizing N276 glycan-deficient HIV after a single immunization with an Env trimer.经过单次 Env 三聚体免疫,能够产生高度突变的抗体,从而中和 N276 糖基缺陷型 HIV。
Cell Rep. 2022 Mar 8;38(10):110485. doi: 10.1016/j.celrep.2022.110485.

引用本文的文献

1
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes.用于引发靶向多个表位的抗体的HIV-1候选疫苗的设计与特性分析
J Exp Med. 2025 Oct 6;222(10). doi: 10.1084/jem.20250693. Epub 2025 Aug 12.
2
The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies.人类免疫缺陷病毒1型包膜糖蛋白:结构、功能及与中和抗体的相互作用
Nat Rev Microbiol. 2025 Jul 23. doi: 10.1038/s41579-025-01206-6.
3
Pregnancy and contraceptive use among participants of childbearing potential in the HVTN 705 HIV vaccine trial in Southern Africa.

本文引用的文献

1
A naturally arising broad and potent CD4-binding site antibody with low somatic mutation.一种自然产生的具有低体细胞突变的广泛且强效的CD4结合位点抗体。
Sci Adv. 2022 Aug 12;8(32):eabp8155. doi: 10.1126/sciadv.abp8155.
2
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env.恒河猴的序贯免疫可诱导针对 HIV-1 Env 的 V3-聚糖补丁的异源中和抗体。
Sci Transl Med. 2021 Nov 24;13(621):eabk1533. doi: 10.1126/scitranslmed.abk1533.
3
Broadly neutralizing monoclonal antibodies for HIV prevention.
南部非洲HVTN 705 HIV疫苗试验中有生育潜力参与者的妊娠及避孕措施使用情况
Front Reprod Health. 2025 Jun 10;7:1565933. doi: 10.3389/frph.2025.1565933. eCollection 2025.
4
Precise targeting of HIV broadly neutralizing antibody precursors in humans.在人类中对HIV广泛中和抗体前体进行精确靶向。
Science. 2025 Jul 31;389(6759):eadv5572. doi: 10.1126/science.adv5572.
5
Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 Env.短的 CDRL1 不足以克服 HIV-1 Env 上的关键聚糖障碍在中等亲和力的 VRC01 样单抗中。
J Virol. 2024 Oct 22;98(10):e0074424. doi: 10.1128/jvi.00744-24. Epub 2024 Sep 6.
6
Injection Drug Use Alters Plasma Regulation of the B Cell Response.注射吸毒改变了 B 细胞反应的血浆调节。
Cells. 2024 Jun 10;13(12):1011. doi: 10.3390/cells13121011.
7
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site.抗体定向进化揭示了 HIV-1 融合肽位点增强中和的机制。
Nat Commun. 2023 Nov 21;14(1):7593. doi: 10.1038/s41467-023-42098-5.
8
Influence of glycosylation on the immunogenicity and antigenicity of viral immunogens.糖基化对病毒免疫原的免疫原性和抗原性的影响。
Biotechnol Adv. 2024 Jan-Feb;70:108283. doi: 10.1016/j.biotechadv.2023.108283. Epub 2023 Nov 14.
9
High throughput analysis of B cell dynamics and neutralizing antibody development during immunization with a novel clade C HIV-1 envelope.新型 HIV-1 包膜 clade C 免疫过程中 B 细胞动态和中和抗体产生的高通量分析
PLoS Pathog. 2023 Oct 25;19(10):e1011717. doi: 10.1371/journal.ppat.1011717. eCollection 2023 Oct.
10
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.种系靶向 HIV-1 Env 疫苗接种诱导具有罕见插入的 VRC01 类抗体。
Cell Rep Med. 2023 Apr 18;4(4):101003. doi: 10.1016/j.xcrm.2023.101003. Epub 2023 Apr 11.
广谱中和单克隆抗体用于 HIV 预防。
J Int AIDS Soc. 2021 Nov;24 Suppl 7(Suppl 7):e25829. doi: 10.1002/jia2.25829.
4
HIV vaccinology: 2021 update.HIV 疫苗学:2021 年更新。
Semin Immunol. 2021 Jan;51:101470. doi: 10.1016/j.smim.2021.101470. Epub 2021 Jul 14.
5
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies.源自抗独特型抗体的 VRC01 类种系靶向免疫原的开发。
Cell Rep. 2021 May 4;35(5):109084. doi: 10.1016/j.celrep.2021.109084.
6
HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors.HIV-1 VRC01 种系靶向免疫原选择不同的表位特异性 B 细胞受体。
Immunity. 2020 Oct 13;53(4):840-851.e6. doi: 10.1016/j.immuni.2020.09.007.
7
UCSF ChimeraX: Structure visualization for researchers, educators, and developers.UCSF ChimeraX:面向研究人员、教育工作者和开发者的结构可视化工具。
Protein Sci. 2021 Jan;30(1):70-82. doi: 10.1002/pro.3943. Epub 2020 Oct 22.
8
B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.表达真实的人类 VRC01 类 BCR 的 B 细胞可以在多个独立的小鼠模型中被招募到生发中心并进行亲和力成熟。
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22920-22931. doi: 10.1073/pnas.2004489117. Epub 2020 Sep 1.
9
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.高度广谱且强效的中和抗体限制 HIV-1 逃逸。
Cell. 2020 Feb 6;180(3):471-489.e22. doi: 10.1016/j.cell.2020.01.010. Epub 2020 Jan 30.
10
Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization.通过免疫克服 VRC01 HIV-1 中和抗体的空间位阻。
Cell Rep. 2019 Dec 3;29(10):3060-3072.e7. doi: 10.1016/j.celrep.2019.10.071.